Evidence map›Paper›PMID 34094333›Full record

ArticleChemical science2020

Demonstration of the utility of DOS-derived fragment libraries for rapid hit derivatisation in a multidirectional fashion.

Sarah L Kidd, Elaine Fowler, Till Reinhardt, Thomas Compton, Natalia Mateu, Hector Newman, Dom Bellini, Romain Talon, Joseph McLoughlin, Tobias Krojer and 14 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Synthesis of spOrganic & biomolecular chemistry · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 5 countries.

Sarah L KiddDepartment of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK spring@ch.cam.ac.uk.ORCID https://orcid.org/0000-0001-9403-8736
Elaine FowlerDepartment of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK spring@ch.cam.ac.uk.ORCID https://orcid.org/0000-0002-6942-646X
Till ReinhardtDepartment of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK spring@ch.cam.ac.uk.
Thomas ComptonDepartment of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK spring@ch.cam.ac.uk.
Natalia MateuDepartment of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK spring@ch.cam.ac.uk.
Hector NewmanSchool of Life Sciences, University of Warwick Coventry UK.
Dom BelliniSchool of Life Sciences, University of Warwick Coventry UK.
Romain TalonDiamond Light Source Ltd., Harwell Science and Innovation Campus Didcot OX11 0QX UK.
Joseph McLoughlinDepartment of Biochemistry, University of Cambridge Tennis Court Road Cambridge CB2 1GA UK.
Tobias KrojerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford Oxford UK.ORCID https://orcid.org/0000-0003-0661-0814
Anthony AimonDiamond Light Source Ltd., Harwell Science and Innovation Campus Didcot OX11 0QX UK.ORCID https://orcid.org/0000-0002-9135-129X
Anthony BradleyDiamond Light Source Ltd., Harwell Science and Innovation Campus Didcot OX11 0QX UK.
Michael FairheadStructural Genomics Consortium (SGC), University of Oxford Oxford OX3 7DQ UK.
Paul BrearDepartment of Biochemistry, University of Cambridge Tennis Court Road Cambridge CB2 1GA UK.ORCID https://orcid.org/0000-0002-4045-0474
Laura Díaz-SáezStructural Genomics Consortium (SGC), University of Oxford Oxford OX3 7DQ UK.
Katherine McAuleyDiamond Light Source Ltd., Harwell Science and Innovation Campus Didcot OX11 0QX UK.
Hannah F SoreDepartment of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK spring@ch.cam.ac.uk.
Andrew MadinHit Discovery, Discovery Sciences, R&D, AstraZeneca Cambridge UK.
Daniel H O'DonovanOncology R&D, AstraZeneca Cambridge CB4 0WG UK.ORCID https://orcid.org/0000-0002-8400-2198
Kilian V M HuberStructural Genomics Consortium (SGC), University of Oxford Oxford OX3 7DQ UK.ORCID https://orcid.org/0000-0002-1103-5300
Marko HyvönenDepartment of Biochemistry, University of Cambridge Tennis Court Road Cambridge CB2 1GA UK.ORCID https://orcid.org/0000-0001-8683-4070
Frank von DelftDiamond Light Source Ltd., Harwell Science and Innovation Campus Didcot OX11 0QX UK.ORCID https://orcid.org/0000-0003-0378-0017
Christopher G DowsonSchool of Life Sciences, University of Warwick Coventry UK.ORCID https://orcid.org/0000-0002-8294-8836
David R SpringDepartment of Chemistry, University of Cambridge Lensfield Road Cambridge CB2 1EW UK spring@ch.cam.ac.uk.ORCID https://orcid.org/0000-0001-7355-2824
University of Cambridge · GBDiamond Light Source · GBTarget (United States) · USAstraZeneca (United Kingdom) · GBUniversity of Warwick · GBStructural Genomics Consortium · CAUniversity of Johannesburg · ZA

Funding

Medical Research Council MR/S014934/1
6 · The paper itself

Abstract

Organic synthesis underpins the evolution of weak fragment hits into potent lead compounds. Deficiencies within current screening collections often result in the requirement of significant synthetic investment to enable multidirectional fragment growth, limiting the efficiency of the hit evolution process. Diversity-oriented synthesis (DOS)-derived fragment libraries are constructed in an efficient and modular fashion and thus are well-suited to address this challenge. To demonstrate the effective nature of such libraries within fragment-based drug discovery, we herein describe the screening of a 40-member DOS library against three functionally distinct biological targets using X-Ray crystallography. Firstly, we demonstrate the importance for diversity in aiding hit identification with four fragment binders resulting from these efforts. Moreover, we also exemplify the ability to readily access a library of analogues from cheap commercially available materials, which ultimately enabled the exploration of a minimum of four synthetic vectors from each molecule. In total, 10-14 analogues of each hit were rapidly accessed in three to six synthetic steps. Thus, we showcase how DOS-derived fragment libraries enable efficient hit derivatisation and can be utilised to remove the synthetic limitations encountered in early stage fragment-based drug discovery.

Identifiers

PMID34094333
PMCPMC8162264
OpenAlexW3025363231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.